From hazard analysis to risk control using rapid methods in microbiology: A practical approach for the food industry

The prevention of foodborne diseases is one of the main objectives of the health authorities. For this purpose, analytical techniques for detecting and / or quantifying the microbiological contamination of food prior to release on the market are required. The management and control of pathogens of food origin have generally been based on conventional detection methodologies, which do not only consume a lot of time and labor, but also involve high consumer material costs. However, this management perspective has changed over time that the food industry requires effective analytical methods that achieve quick results.
This review covers the historical context of traditional methods and their passage in the latest developments of rapid methods and their implementation in the food sector. Improvements and limitations in the detection of the most relevant pathogens are discussed from a perspective applicable to the current situation in the food industry. Given the efforts and recent developments, fast and accurate methods already used in the food industry will also be affordable and portable and provide connectivity in the near future, which improves decision-making and safety throughout the chain Food. A retrospective epidemiological study describing the characteristics, the incidence rates (IR) and the microbiological etiology of the SCAP in Central Australia.
Adult Patients Admitted to Alice Springs Hospital Intensive Care Unit (ICU) between 2011-2014 which has been included the IDSA / ATS definition of the SCAP. Medical records have been examined and compared between Aboriginal and non-Aboriginal patients. Primary results were an incidence rate and microbiological etiology of SCAP. Secondary results were 30 days mortality and a residence time of the ICU and the hospital (LOS).
Plancostomycetes as bacteria associated with the host: a perspective that keeps the promise of their future isolates, imitating their aboriginal environmental niches in clinical microbiology laboratories
Traditionally recognized as environmental bacteria, plancostomycetes have recently been linked to human pathology as opportunistic pathogens, providing great interest to clinical microbiologists. However, the absence of appropriate culture media limits our future surveys because no plackctomyte has ever been isolated from patient specimens despite multiple attempts. Several plancostomycetes have no cultivable members and are recognized only by detecting and analyzing the sequence of the arrn genes. Cultivated representatives are tedious slow growth bacteria and most of the time culture on synthetic media.
As a result, the provision of environmental and nutritional conditions such as those existing in natural habitat in natural habitat where non-skin / refractory bacteria can be detected could be an option for their potential isolation. As a result, we have systematically examined the different natural plancostomycete habitats, to examine their nutritional requirements, the physicochemical characteristics of their natural ecological niches, the current methods of cultivation of plackcetes and gaps, from a perspective of data collection. to optimize the conditions and the culture protocols of these tedious bacteria.
Plancptomycetes are prevalent in freshwater, seawater and terrestrial environments, mainly associated with particles or organisms such as macroalgae, marine sponges and lichens, depending on the species and polysaccharides metabolizable by their sulfatasis. Most plancostomycetes are developing in poor nutrient oligotrophic environments with a pH ranging from 3.4 to 11, but some strains can also develop in media rich in nutrients such as M600 / M14. In addition, a variation in seasonality of abundance is observed and flowering occurs in the summer-early autumn, correlated with strong algae growth in marine environments. Most placalcètes are mesophilic, but with some plancostomycetes being thermophilic (50 ° C to 60 ° C).

Mini Review: Clinical Routine Microbiology in the Era of Digital Automation and Health
Clinical microbiology laboratories are the first line of infectious disease and antibiotic resistance, including new emerging. Although most clinical laboratories are still based on conventional methods, a cascade of technological change, driven by digital imaging and high-speed sequencing, will revolutionize clinical diagnostics management for direct detection of bacteria and susceptibility testing. rapid antimicrobial. IMPORTANT, such technological advances occur in the golden age of machines learning where computers do not act more passively in the mining of data, but once trained, can also help doctors take Decisions on the optimal diagnosis and administration of treatment.
The additional physical integration potential of new technologies in an automation chain, associated with the software to the automatic learning of data analyzes, is seduced and lead to faster management of infectious diseases. However, if, on the one hand, the technological advancement would have a better performance than conventional methods, on the other side, this evolution disputes clinicians in terms of data interpretation and impact on the whole of the Organization and management of the staff of the hospital.
![]() ELISA kit for Mouse Histamine |
|||
KTE71604-48T | Abbkine | 48T | EUR 354 |
Description: Quantitative sandwich ELISA for measuring Mouse Histamine in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
![]() ELISA kit for Mouse Histamine |
|||
KTE71604-5platesof96wells | Abbkine | 5 plates of 96 wells | EUR 2252 |
Description: Quantitative sandwich ELISA for measuring Mouse Histamine in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
![]() ELISA kit for Mouse Histamine |
|||
KTE71604-96T | Abbkine | 96T | EUR 572 |
Description: Quantitative sandwich ELISA for measuring Mouse Histamine in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
![]() ELISA kit for Rat Histamine |
|||
KTE101102-48T | Abbkine | 48T | EUR 354 |
Description: Quantitative sandwich ELISA for measuring Rat Histamine in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
![]() ELISA kit for Rat Histamine |
|||
KTE101102-5platesof96wells | Abbkine | 5 plates of 96 wells | EUR 2252 |
Description: Quantitative sandwich ELISA for measuring Rat Histamine in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
![]() ELISA kit for Human Histamine |
|||
KTE62938-48T | Abbkine | 48T | EUR 354 |
Description: Quantitative sandwich ELISA for measuring Human Histamine in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
![]() ELISA kit for Human Histamine |
|||
KTE62938-5platesof96wells | Abbkine | 5 plates of 96 wells | EUR 2252 |
Description: Quantitative sandwich ELISA for measuring Human Histamine in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
![]() ELISA kit for Human Histamine |
|||
KTE62938-96T | Abbkine | 96T | EUR 572 |
Description: Quantitative sandwich ELISA for measuring Human Histamine in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
![]() ELISA kit for Rat Histamine |
|||
KTE101102-96T | Abbkine | 96T | EUR 572 |
Description: Quantitative sandwich ELISA for measuring Rat Histamine in samples from cell culture supernatants, serum, whole blood, plasma and other biological fluids. |
![]() ELISA kit for HIS (Histamine) |
|||
E-EL-0032 | Elabscience Biotech | 1 plate of 96 wells | EUR 377 |
Description: A competitive ELISA kit for quantitative measurement of HIS (Histamine) in samples from Serum, Plasma, Cell supernatant |
![]() ELISA kit for General Histamine |
|||
EK2448 | SAB | 96 tests | EUR 603 |
Description: Enzyme-linked immunosorbent assay kit for quantification of General Histamine in samples from serum, plasma, tissue homogenates and other biological fluids. |
![]() Histamine |
|||
20-abx182483 | Abbexa |
|
|
![]() Histamine |
|||
RA22939 | Neuromics | 100 ul | EUR 409 |
![]() Histamine |
|||
HB0500 | Bio Basic | 1g | EUR 126.56 |
![]() Histamine |
|||
HY-B1204 | MedChemExpress | 10mM/1mL | EUR 126 |
![]() ELISA kit for General HA (Histamine) |
|||
ELK7869 | ELK Biotech | 1 plate of 96 wells | EUR 372 |
Description: A competitive Inhibition ELISA kit for detection of Histamine from General in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
![]() ELISA kit for General HA (Histamine) |
|||
ELK8094 | ELK Biotech | 1 plate of 96 wells | EUR 372 |
Description: A competitive Inhibition ELISA kit for detection of Histamine from General in samples from blood, serum, plasma, cell culture fluid and other biological fluids. |
![]() Histamine-BSA |
|||
80-1460 | Fitzgerald | 1 mg | EUR 349 |
Description: BSA conjugated Histamine Hapten |
![]() Histamine-OVA |
|||
80-1461 | Fitzgerald | 1 mg | EUR 349 |
Description: OVA conjugated Histamine Hapten |
![]() Histamine-OVA |
|||
80-1462 | Fitzgerald | 1 mg | EUR 349 |
Description: OVA conjugated Histamine Hapten |
![]() Histamine antibody |
|||
20R-HR017 | Fitzgerald | 50 uL | EUR 918 |
Description: Rabbit polyclonal Histamine antibody |
![]() Histamine antibody |
|||
PAab09932 | Lifescience Market | 100 ug | EUR 386 |
![]() Histamine (BSA) |
|||
20-abx165751 | Abbexa |
|
|
![]() Histamine (OVA) |
|||
20-abx165752 | Abbexa |
|
|
![]() Histamine (phosphate) |
|||
HY-A0129 | MedChemExpress | 1g | EUR 119 |
![]() Histamine diphosphate |
|||
HB0502 | Bio Basic | 5g | EUR 63.92 |
![]() Histamine 2HCl |
|||
B1561-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 108 |
Description: Histamine is an organic nitrogen compound, acts on target cells in mammalian brain via stimulation of Histamine 1/2. |
![]() Histamine 2HCl |
|||
B1561-50 | ApexBio | 50 mg | EUR 128 |
Description: Histamine is an organic nitrogen compound, acts on target cells in mammalian brain via stimulation of Histamine 1/2. |
![]() Histamine 2HCl |
|||
B1561-S | ApexBio | Evaluation Sample | EUR 81 |
Description: Histamine is an organic nitrogen compound, acts on target cells in mammalian brain via stimulation of Histamine 1/2. |
![]() Histamine Phosphate |
|||
B1770-5.1 | ApexBio | 10 mM (in 1mL DMSO) | EUR 108 |
Description: Histamine acts directly on the blood vessels to dilate arteries and capillaries mediated by both H 1- and H 2-receptors. |
![]() Histamine Phosphate |
|||
B1770-50 | ApexBio | 50 mg | EUR 128 |
Description: Histamine acts directly on the blood vessels to dilate arteries and capillaries mediated by both H 1- and H 2-receptors. |
![]() Febrifugine dihydrochloride |
|||
TBW01154 | ChemNorm | 10mg | Ask for price |
![]() Bisantrene dihydrochloride |
|||
B2736-25 | Biovision | 25 mg | EUR 480 |
![]() Bisantrene dihydrochloride |
|||
B2736-5 | Biovision | 5 mg | EUR 166 |
![]() Cystamine dihydrochloride |
|||
B2982-1 | Biovision | 1 g | EUR 110 |
![]() Cystamine dihydrochloride |
|||
B2982-5 | Biovision | 5 g | EUR 293 |
![]() Cetirizine dihydrochloride |
|||
B2993-100 | Biovision | 100mg | EUR 110 |
![]() Cetirizine dihydrochloride |
|||
B2993-500 | Biovision | 500mg | EUR 287 |
![]() SA4503 dihydrochloride |
|||
B3046-25 | Biovision | 25 mg | EUR 510 |
![]() SA4503 dihydrochloride |
|||
B3046-5 | Biovision | 5 mg | EUR 166 |
![]() Vatalanib Dihydrochloride |
|||
2025-25 | Biovision | EUR 305 |
![]() Vatalanib Dihydrochloride |
|||
2025-5 | Biovision | EUR 126 |
![]() 1400W dihydrochloride |
|||
2055-25 | Biovision | EUR 338 |
![]() 1400W dihydrochloride |
|||
2055-5 | Biovision | EUR 126 |
![]() Norquetiapine dihydrochloride |
|||
2362-250 | Biovision | EUR 414 |
![]() Norquetiapine dihydrochloride |
|||
2362-50 | Biovision | EUR 142 |
![]() Berbamine dihydrochloride |
|||
2520-100 | Biovision | EUR 131 |
![]() Berbamine dihydrochloride |
|||
2520-500 | Biovision | EUR 370 |
![]() Antipain dihydrochloride |
|||
2834-25 | Biovision | EUR 327 |
![]() Antipain dihydrochloride |
|||
2834-5 | Biovision | EUR 120 |
![]() Dorsmorphin dihydrochloride |
|||
2835-25 | Biovision | EUR 588 |
![]() Dorsmorphin dihydrochloride |
|||
2835-5 | Biovision | EUR 185 |
![]() GGACK Dihydrochloride |
|||
1847-5 | Biovision | 5 mg | EUR 319 |
Description: A potent and irreversible inhibitor of Urokinase (uPA (IC??<1 µM), Factor VIIa, Factor IXa, Factor Xa, and trypsin. |
![]() PPACK Dihydrochloride |
|||
1848-5 | Biovision | EUR 251 |
![]() Puromycin Dihydrochloride |
|||
1860-100 | Biovision | EUR 272 |
![]() Puromycin Dihydrochloride |
|||
1860-1000 | Biovision | EUR 1295 |
![]() Puromycin Dihydrochloride |
|||
1860-25 | Biovision | EUR 126 |
![]() Puromycin Dihydrochloride |
|||
1860-250 | Biovision | EUR 457 |
![]() Puromycin Dihydrochloride |
|||
1860-500 | Biovision | EUR 805 |
![]() Emetine dihydrochloride |
|||
1970-250 | Biovision | EUR 359 |
![]() Emetine dihydrochloride |
|||
1970-50 | Biovision | EUR 137 |
![]() Dexpramipexole dihydrochloride |
|||
B2215-25 | Biovision | EUR 457 |
![]() Dexpramipexole dihydrochloride |
|||
B2215-5 | Biovision | EUR 153 |
![]() Daclatasvir dihydrochloride |
|||
B2224-25 | Biovision | EUR 414 |
![]() Daclatasvir dihydrochloride |
|||
B2224-5 | Biovision | EUR 142 |
![]() Netarsudil dihydrochloride |
|||
B2387-25 | Biovision | EUR 457 |
![]() Netarsudil dihydrochloride |
|||
B2387-5 | Biovision | EUR 153 |
![]() Furamidine dihydrochloride |
|||
B2581-25 | Biovision | EUR 544 |
![]() Furamidine dihydrochloride |
|||
B2581-5 | Biovision | EUR 175 |
![]() Cefotiam Dihydrochloride |
|||
C095-100MG | TOKU-E | 100 mg | EUR 232 |
![]() Cefotiam Dihydrochloride |
|||
C095-50MG | TOKU-E | 50 mg | EUR 144 |
![]() Chlorhexidine Dihydrochloride |
|||
C157-25G | TOKU-E | 25 g | EUR 185 |
![]() Chlorhexidine Dihydrochloride |
|||
C157-5G | TOKU-E | 5 g | EUR 72 |
![]() Antipain, dihydrochloride |
|||
ADJ692 | Bio Basic | 5mg | EUR 92.11 |
![]() Piperazine Dihydrochloride |
|||
abx180858-100g | Abbexa | 100 g | EUR 230 |
![]() Pramipexole dihydrochloride |
|||
20-abx180860 | Abbexa |
|
|
![]() Vatalanib Dihydrochloride |
|||
20-abx076544 | Abbexa |
|
|
![]() DMPQ Dihydrochloride |
|||
20-abx076714 | Abbexa |
|
|
![]() H89 Dihydrochloride |
|||
20-abx076747 | Abbexa |
|
|
![]() TMB dihydrochloride |
|||
TB0514 | Bio Basic | 1g | EUR 70.88 |
![]() Puromycin dihydrochloride |
|||
GA1940-100MG | Glentham Life Sciences | 100 mg | EUR 245 |
![]() Puromycin dihydrochloride |
|||
GA1940-10MG | Glentham Life Sciences | 10 mg | EUR 70 |
![]() Puromycin dihydrochloride |
|||
GA1940-250MG | Glentham Life Sciences | 250 mg | EUR 469 |
![]() Puromycin dihydrochloride |
|||
GA1940-25MG | Glentham Life Sciences | 25 mg | EUR 110 |
![]() Puromycin dihydrochloride |
|||
GA1940-500MG | Glentham Life Sciences | 500 mg | EUR 819 |
![]() Ethambutol dihydrochloride |
|||
GA7275-100G | Glentham Life Sciences | 100 g | EUR 269 |
![]() Ethambutol dihydrochloride |
|||
GA7275-25G | Glentham Life Sciences | 25 g | EUR 94 |
![]() Ethylenediamine dihydrochloride |
|||
GK6724-100G | Glentham Life Sciences | 100 g | EUR 54 |
![]() Ethylenediamine dihydrochloride |
|||
GK6724-250G | Glentham Life Sciences | 250 g | EUR 86 |
![]() Ethylenediamine dihydrochloride |
|||
GK6724-500G | Glentham Life Sciences | 500 g | EUR 118 |
![]() 1400W dihydrochloride |
|||
GK6799-100MG | Glentham Life Sciences | 100 mg | EUR 551 |
![]() 1400W dihydrochloride |
|||
GK6799-25MG | Glentham Life Sciences | 25 mg | EUR 229 |
![]() 1400W dihydrochloride |
|||
GK6799-5MG | Glentham Life Sciences | 5 mg | EUR 114 |
![]() Hydroxyzine dihydrochloride |
|||
GK7844-10G | Glentham Life Sciences | 10 g | EUR 126 |
![]() Cystamine dihydrochloride |
|||
GK9885-100G | Glentham Life Sciences | 100 g | EUR 82 |
![]() Cystamine dihydrochloride |
|||
GK9885-250G | Glentham Life Sciences | 250 g | EUR 142 |
![]() Cystamine dihydrochloride |
|||
GK9885-25G | Glentham Life Sciences | 25 g | EUR 50 |
![]() SAG dihydrochloride |
|||
GL1175-1MG | Glentham Life Sciences | 1 mg | EUR 195 |
![]() SAG dihydrochloride |
|||
GL1175-5MG | Glentham Life Sciences | 5 mg | EUR 574 |
![]() Trifluoperazine dihydrochloride |
|||
GL5164-10G | Glentham Life Sciences | 10 g | EUR 110 |
![]() Trifluoperazine dihydrochloride |
|||
GL5164-25G | Glentham Life Sciences | 25 g | EUR 186 |
![]() Antipain dihydrochloride |
|||
GL6582-25MG | Glentham Life Sciences | 25 mg | EUR 235 |
![]() Opipramol dihydrochloride |
|||
GL4485-100MG | Glentham Life Sciences | 100 mg | EUR 174 |
![]() Opipramol dihydrochloride |
|||
GL4485-1G | Glentham Life Sciences | 1 g | EUR 628 |
![]() Trifluoperazine dihydrochloride |
|||
GL5164-5G | Glentham Life Sciences | 5 g | EUR 78 |
![]() Antipain dihydrochloride |
|||
GL6582-5MG | Glentham Life Sciences | 5 mg | EUR 114 |
![]() Retigabine dihydrochloride |
|||
GP0386-100MG | Glentham Life Sciences | 100 mg | EUR 95 |
![]() Retigabine dihydrochloride |
|||
GP0386-250MG | Glentham Life Sciences | 250 mg | EUR 139 |
![]() Pirenzepine dihydrochloride |
|||
GP0823-1G | Glentham Life Sciences | 1 g | EUR 174 |
![]() Pirenzepine dihydrochloride |
|||
GP0823-250MG | Glentham Life Sciences | 250 mg | EUR 78 |
![]() Pirenzepine dihydrochloride |
|||
GP0823-500MG | Glentham Life Sciences | 500 mg | EUR 110 |
![]() Nolatrexed dihydrochloride |
|||
GP7069-5MG | Glentham Life Sciences | 5 mg | EUR 78 |
![]() Pyridoxamine dihydrochloride |
|||
GP8560-1G | Glentham Life Sciences | 1 g | EUR 58 |
![]() Putrescine dihydrochloride |
|||
GP9873-100G | Glentham Life Sciences | 100 g | EUR 94 |
![]() Putrescine dihydrochloride |
|||
GP9873-10G | Glentham Life Sciences | 10 g | EUR 52 |
![]() Putrescine dihydrochloride |
|||
GP9873-1G | Glentham Life Sciences | 1 g | EUR 44 |
![]() Putrescine dihydrochloride |
|||
GP9873-25G | Glentham Life Sciences | 25 g | EUR 61 |
![]() Octenidine dihydrochloride |
|||
GP2536-10G | Glentham Life Sciences | 10 g | EUR 150 |
![]() Octenidine dihydrochloride |
|||
GP2536-1G | Glentham Life Sciences | 1 g | EUR 50 |
![]() Octenidine dihydrochloride |
|||
GP2536-5G | Glentham Life Sciences | 5 g | EUR 98 |
![]() Cetirizine dihydrochloride |
|||
GP4015-1G | Glentham Life Sciences | 1 g | EUR 66 |
![]() Cetirizine dihydrochloride |
|||
GP4015-250MG | Glentham Life Sciences | 250 mg | EUR 52 |
![]() Cetirizine dihydrochloride |
|||
GP4015-5G | Glentham Life Sciences | 5 g | EUR 110 |
![]() Puromycin Dihydrochloride |
|||
P001-1G | TOKU-E | 1 g | EUR 504 |
![]() Puromycin Dihydrochloride |
|||
P001-250MG | TOKU-E | 250 mg | EUR 160 |
![]() Puromycin Dihydrochloride |
|||
P001-500MG | TOKU-E | 500 mg | EUR 285 |
![]() Putrescine Dihydrochloride |
|||
P103-100G | TOKU-E | 100 g | EUR 157 |
![]() Putrescine Dihydrochloride |
|||
P103-25G | TOKU-E | 25 g | EUR 56 |
![]() Latrepirdine (dihydrochloride) |
|||
HY-14537 | MedChemExpress | 10mM/1mL | EUR 113 |
![]() Inolitazone (dihydrochloride) |
|||
HY-14792B | MedChemExpress | 5mg | EUR 544 |
![]() Bavisant (dihydrochloride) |
|||
HY-14880A | MedChemExpress | 5mg | EUR 326 |
![]() Mirodenafil (dihydrochloride) |
|||
HY-14930A | MedChemExpress | 50mg | EUR 2116 |
![]() SCH79797 (dihydrochloride) |
|||
HY-14994 | MedChemExpress | 10mg | EUR 1175 |
![]() Ipatasertib dihydrochloride |
|||
HY-15186A | MedChemExpress | 50mg | EUR 383 |
![]() GW791343 (dihydrochloride) |
|||
HY-15469 | MedChemExpress | 5mg | EUR 147 |
![]() Merestinib dihydrochloride |
|||
HY-15514A | MedChemExpress | 10mg | EUR 354 |
![]() Mibefradil (dihydrochloride) |
|||
HY-15553A | MedChemExpress | 10mg | EUR 259 |
![]() Ceritinib dihydrochloride |
|||
HY-15656A | MedChemExpress | 5mg | EUR 108 |
![]() CRT0066101 dihydrochloride |
|||
HY-15698A | MedChemExpress | 25mg | EUR 463 |
![]() Flupentixol dihydrochloride |
|||
HY-15856B | MedChemExpress | 10mg | EUR 131 |
![]() TMB (dihydrochloride) |
|||
HY-15930A | MedChemExpress | 10mM/1mL | EUR 113 |
![]() Eravacycline (dihydrochloride) |
|||
HY-16980A | MedChemExpress | 10mM/1mL | EUR 146 |
![]() Pirenzepine (dihydrochloride) |
|||
HY-17037 | MedChemExpress | 500mg | EUR 160 |
![]() Cetirizine (dihydrochloride) |
|||
HY-17042A | MedChemExpress | 10mM/1mL | EUR 126 |
![]() Pramipexole (dihydrochloride) |
|||
HY-17355 | MedChemExpress | 10mg | EUR 119 |
![]() Dexpramipexole (dihydrochloride) |
|||
HY-17355A | MedChemExpress | 10mg | EUR 153 |
![]() Ranolazine (dihydrochloride) |
|||
HY-17401 | MedChemExpress | 10mM/1mL | EUR 156 |
![]() Manidipine (dihydrochloride) |
|||
HY-17403 | MedChemExpress | 10mM/1mL | EUR 134 |
![]() Prexasertib (dihydrochloride) |
|||
HY-18174A | MedChemExpress | 100mg | EUR 1083 |
![]() Azimilide (Dihydrochloride) |
|||
HY-18600A | MedChemExpress | 100mg | EUR 1083 |
![]() 1400W (Dihydrochloride) |
|||
HY-18731 | MedChemExpress | 10mM/1mL | EUR 126 |
![]() MS023 (dihydrochloride) |
|||
HY-19615B | MedChemExpress | 100mg | EUR 911 |
![]() DG172 (dihydrochloride) |
|||
HY-19737A | MedChemExpress | 50mg | EUR 587 |
![]() Elacestrant (dihydrochloride) |
|||
HY-19822A | MedChemExpress | 10mM/1mL | EUR 613 |
![]() Talipexole dihydrochloride |
|||
HY-A0008 | MedChemExpress | 10mM/1mL | EUR 179 |
In this mini-examination, we discuss such technological achievements offering practical examples of their operability, but also their limits and potential problems that their implementation could increase in clinical microbiology laboratories.